rs886039434
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PP2PP3_ModeratePP5_Very_Strong
The NM_139276.3(STAT3):c.1979T>C(p.Met660Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_139276.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
The M660T variant has been published in association with hyper IgE syndrome (Schimke et al., 2010). The M660T variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The M660T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position located within the SH2 domain that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, this variant is likely pathogenic. -
PP2, PP3, PM1, PM2, PM6, PS3_supporting, PS4 -
Hyper-IgE syndrome Pathogenic:2
Variant summary: The STAT3 c.1979T>C (p.Met660Thr) variant involves the alteration of a conserved nucleotide located in the Src homology domain 2 of STAT3 and results in a replacement of a medium size and hydrophobic Methionine (M) with a medium size and polar Threonine (T). 4/4 in silico tools predict a damaging outcome for this substitution (SNPs&GO not captured due to low reliability index). This variant is absent in 121612 control chromosomes while it was reported in Hyper IgE Syndrome patients indicating pathogenicity. Moreover, in one patient, the variant emerged de novo strongly suggesting a deleterious outcome. Studies assessing the impact the variant may have on the function of the STAT3 protein were not published at the time of classification. Taken together, this variant is classified as probably pathogenic. -
PS2,PS3,PM2,PP3 -
Hyper-IgE recurrent infection syndrome 1, autosomal dominant;C4288261:STAT3 gain of function Pathogenic:1
Experimental studies have shown that this missense change disrupts protein function (PMID: 28315006, 29868029). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Met660 amino acid residue in STAT3. Other variant(s) that disrupt this residue have been observed in affected individuals (PMID: 21792878), which suggests that this may be a clinically significant amino acid residue. This variant has been observed in individuals affected with hyper IgE syndrome, including an individual in which the variant occurred de novo (PMID: PMID: 20816194, 28315006). ClinVar contains an entry for this variant (Variation ID: 265261). This variant is not present in population databases (ExAC no frequency). This sequence change replaces methionine with threonine at codon 660 of the STAT3 protein (p.Met660Thr). The methionine residue is highly conserved and there is a moderate physicochemical difference between methionine and threonine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at